• Something wrong with this record ?

Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals

K. Braune, RA. Lal, L. Petruželková, G. Scheiner, P. Winterdijk, S. Schmidt, L. Raimond, KK. Hood, MC. Riddell, TC. Skinner, K. Raile, S. Hussain, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group

. 2022 ; 10 (1) : 58-74. [pub] 20211113

Language English Country Great Britain

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc22019556

Grant support
Wellcome Trust - United Kingdom
K12 DK122550 NIDDK NIH HHS - United States
K23 DK122017 NIDDK NIH HHS - United States
P30 DK116074 NIDDK NIH HHS - United States

Open-source automated insulin delivery systems, commonly referred to as do-it-yourself automated insulin delivery systems, are examples of user-driven innovations that were co-created and supported by an online community who were directly affected by diabetes. Their uptake continues to increase globally, with current estimates suggesting several thousand active users worldwide. Real-world user-driven evidence is growing and provides insights into safety and effectiveness of these systems. The aim of this consensus statement is two-fold. Firstly, it provides a review of the current evidence, description of the technologies, and discusses the ethics and legal considerations for these systems from an international perspective. Secondly, it provides a much-needed international health-care consensus supporting the implementation of open-source systems in clinical settings, with detailed clinical guidance. This consensus also provides important recommendations for key stakeholders that are involved in diabetes technologies, including developers, regulators, and industry, and provides medico-legal and ethical support for patient-driven, open-source innovations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019556
003      
CZ-PrNML
005      
20220804135754.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/S2213-8587(21)00267-9 $2 doi
035    __
$a (PubMed)34785000
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Braune, Katarina $u Department of Paediatric Endocrinology and Diabetes, Charité-Universitätsmedizin Berlin, Berlin, Germany; Institute of Medical Informatics, Charité-Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany
245    10
$a Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals / $c K. Braune, RA. Lal, L. Petruželková, G. Scheiner, P. Winterdijk, S. Schmidt, L. Raimond, KK. Hood, MC. Riddell, TC. Skinner, K. Raile, S. Hussain, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group
520    9_
$a Open-source automated insulin delivery systems, commonly referred to as do-it-yourself automated insulin delivery systems, are examples of user-driven innovations that were co-created and supported by an online community who were directly affected by diabetes. Their uptake continues to increase globally, with current estimates suggesting several thousand active users worldwide. Real-world user-driven evidence is growing and provides insights into safety and effectiveness of these systems. The aim of this consensus statement is two-fold. Firstly, it provides a review of the current evidence, description of the technologies, and discusses the ethics and legal considerations for these systems from an international perspective. Secondly, it provides a much-needed international health-care consensus supporting the implementation of open-source systems in clinical settings, with detailed clinical guidance. This consensus also provides important recommendations for key stakeholders that are involved in diabetes technologies, including developers, regulators, and industry, and provides medico-legal and ethical support for patient-driven, open-source innovations.
650    12
$a diabetes mellitus 1. typu $x farmakoterapie $7 D003922
650    _2
$a zdravotnický personál $7 D006282
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x terapeutické užití $7 D007004
650    12
$a inzulin $x terapeutické užití $7 D007328
650    _2
$a inzulinové infuzní systémy $7 D007332
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Lal, Rayhan A $u Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford University, Stanford, CA, USA. Electronic address: inforay@stanford.edu
700    1_
$a Petruželková, Lenka $u Department of Pediatrics, University Hospital Motol, Prague, Czech Republic
700    1_
$a Scheiner, Gary $u Integrated Diabetes Services, Wynnewood, PA, USA
700    1_
$a Winterdijk, Per $u Diabeter, Center for Pediatric and Adult Diabetes Care and Research, Rotterdam, Netherlands
700    1_
$a Schmidt, Signe $u Steno Diabetes Center Copenhagen, Gentofte, Denmark
700    1_
$a Raimond, Linda $u Steno Diabetes Center Copenhagen, Gentofte, Denmark
700    1_
$a Hood, Korey K $u Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
700    1_
$a Riddell, Michael C $u Muscle Health Research Centre, York University, Toronto, ON, Canada
700    1_
$a Skinner, Timothy C $u Department of Psychology, University of Copenhagen, Copenhagen, Denmark; La Trobe Rural Health School, La Trobe University, Bendigo, VIC, Australia
700    1_
$a Raile, Klemens $u Department of Paediatric Endocrinology and Diabetes, Charité-Universitätsmedizin Berlin, Berlin, Germany
700    1_
$a Hussain, Sufyan $u Department of Diabetes and Endocrinology, Guy's and St Thomas' Hospital NHS Trust, London, UK; Department of Diabetes, King's College London, London, UK; Institute of Diabetes, Endocrinology and Obesity, King's Health Partners, London, UK. Electronic address: sufyan.hussain@kcl.ac.uk
710    2_
$a OPEN International Healthcare Professional Network and OPEN Legal Advisory Group
773    0_
$w MED00186388 $t The lancet. Diabetes & endocrinology $x 2213-8595 $g Roč. 10, č. 1 (2022), s. 58-74
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34785000 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135748 $b ABA008
999    __
$a ok $b bmc $g 1822957 $s 1170799
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 1 $d 58-74 $e 20211113 $i 2213-8595 $m The lancet. Diabetes & endocrinology $n Lancet Diabetes Endocrinol $x MED00186388
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a K12 DK122550 $p NIDDK NIH HHS $2 United States
GRA    __
$a K23 DK122017 $p NIDDK NIH HHS $2 United States
GRA    __
$a P30 DK116074 $p NIDDK NIH HHS $2 United States
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options